MENU

NTLA Intellia Therapeutics Forecast, Technical & Fundamental Analysis

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics... Show more

Industry: #Biotechnology
NTLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
NTLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NTLA is expected to report earnings to -80 cents per share on November 05

Intellia Therapeutics NTLA Stock Earnings Reports
Q3'26
Est.
$-0.80
Q2'26
Est.
$-0.80
Q1'26
Beat
by $0.10
Q4'25
Beat
by $0.13
Q3'25
Beat
by $0.09
The last earnings report on August 06 showed earnings per share of -80 cents, meeting the estimate of -80 cents. With 3.02M shares outstanding, the current market capitalization sits at 1.78B.
A.I. Advisor
published General Information

General Information

a developer of proprietary, potentially curative therapeutics

Industry Biotechnology

Industry
Biotechnology
Address
40 Erie Street
Phone
+1 857 285-6200
Employees
377
Web
https://www.intelliatx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QQQE121.711.02
+0.85%
Direxion NASDAQ-100 Equal Weighted Index ETF (QQQE)
DDTO23.660.04
+0.15%
Innovator Equity Dual Directional 10 Buffer ETF - October (DDTO)
BSJU25.36N/A
N/A
Invesco BulletShares 2030 High Yield Corporate Bond ETF (BSJU)
LIAU248.49N/A
N/A
LifeX 2060 Inflation-Protected Longevity Income ETF (LIAU)
SSK15.96-0.01
-0.09%
REX-Osprey SOL + Staking ETF (SSK)

NTLA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+3.85%
VCYT - NTLA
69%
Closely correlated
+4.43%
CRSP - NTLA
63%
Loosely correlated
+1.20%
BEAM - NTLA
61%
Loosely correlated
+2.65%
PRME - NTLA
58%
Loosely correlated
+10.97%
EDIT - NTLA
56%
Loosely correlated
+3.18%
More
Intellia Therapeutics (NTLA) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com